Statistics
Publications
5
Citations
140
H-Index
5
Active since
2019
Maryl Wright is an author at Tulane University specializing in oncology, medicine, and molecular oncology.
Publications per year
2019–2022
5
5
Ceritinib is a novel triple negative breast cancer therapeutic agent
Shengli Dong, Hassan Yousefi, Isabella Van Savage et al. · Molecular Cancer · 2022 · 35 citations · Full text
Medicine, Oncology, Pharmacology +16
Margarite D. Matossian, Tiffany Chang, Maryl Wright et al. · Clinical & Translational Oncology · 2021 · 22 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 5